| 976 |
disrupted |
regulation of gene expression
(GO:0010468)
|
|
2224: Dysregulation of transcriptional expression within PPAR signaling network
|
| 977 |
disrupted |
lipid storage
(GO:0019915)
|
|
2225: Disrupted Lipid Storage
|
| 978 |
increased |
vasoconstriction
(GO:0042310)
|
kidney afferent arteriole smooth muscle cell
(CL:1001097)
|
2230: Increased, afferent artery vasoconstriction
|
| 979 |
increased |
positive regulation of translation
(GO:0045727)
|
cytochrome P450
(CHEBI:38559)
|
None
|
| 980 |
decreased |
|
neuropathy target esterase
(PR:000012946)
|
2243: Neuropathy target esterase, inhibited
|
| 981 |
increased |
|
lysophosphatidylcholine
(CHEBI:60479)
|
2244: Lysolecithin, increased
|
| 982 |
increased |
cell death
(GO:0008219)
|
oligodendrocyte
(CL:0000128)
|
2246: Oligodendrocyte death, increased
|
| 983 |
increased |
demyelination
(MP:0000921)
|
|
2247: Demyelination, increased
|
| 984 |
increased |
CNS demyelination
(HP:0007305)
|
|
2247: Demyelination, increased
|
| 985 |
increased |
cell death
(GO:0008219)
|
cell
(GO:0005623)
|
1829: Altered, Thyroid hormone-dependent gene expression
|
| 986 |
increased |
cell death
(GO:0008219)
|
bone cell
(CL:0001035)
|
1825: Increase, Cell death
|